Clinical Trial Update: Nab-Paclitaxel/STI-3031 Complex (AP160-Complex) for the Treatment of Advanced or Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 trial of Nab-Paclitaxel in combination with STI-3031 Complex (AP160-Complex) for advanced or metastatic solid tumors has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors
• Unresectable Melanoma

Drugs mentioned

• Nab-paclitaxel (paclitaxel protein-bound)
• STI-3031 Complex (AP160-Complex)

Snippet

Sponsor: Mayo Clinic | Conditions: Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm | Phase 1 | Status: WITHDRAWN